Drugs News and Research

RSS

Report on versatility of nitric oxide in arming hosts against pathogens

A new target for nitric oxide has been revealed in studies of how it inhibits the growth of Salmonella. This bacterium is a common cause of food-poisoning.

25 Jul 2011

Medicines Patent Pool can help many but has potential limitations for AIDS drug access in middle-income countries

In a post on the New York Times' "Opinionator" blog, author and journalist Tina Rosenberg writes about the Medicines Patent Pool (MPP) and describes how it can help purchase AIDS drugs for "vast numbers of people."

25 Jul 2011

Circumcision prevents HIV transmission & cocktail of anti-HIV drugs prolong life

Reports came in last Wednesday that circumcision reduces transmission of HIV, in regions where transmission is high. To researchers, this procedure proves to be a cost-effective way to handle the pandemic. In South Africa, a study reported that men with circumcisions reduced new HIV infections by 76%.

24 Jul 2011

Homeless people report using street drugs to treat their pain

Chronic pain is not managed well in the general population and it's an even greater challenge for homeless people, according to new research by St. Michael's Hospital.

22 Jul 2011

Senate Dems push for Medicare drug savings

During a hearing this week, Senate Democrats, including Aging Committee Chairman Herb Kohl, D-Wis., advanced the causes of certain policies to control drug costs and reduce deficit spending.

22 Jul 2011

U.S. healthcare inflation seems to be leveling off

The cost of medical care for people in employer-sponsored health plans rose at an annualized rate of 3.8 percent in the first quarter of 2011, according to the Thomson Reuters Healthcare Spending Index for Private Insurance.

22 Jul 2011

Myelin regulates key protein involved in sending long-distance signals

The development of a new cell-culture system that mimics how specific nerve cell fibers in the brain become coated with protective myelin opens up new avenues of research about multiple sclerosis. Initial findings suggest that myelin regulates a key protein involved in sending long-distance signals.

22 Jul 2011

22nd Century receives FDA approval for X-22 IND to conduct Phase II-B smoking cessation trial

22nd Century Group, Inc., a company focused on smoking cessation and tobacco harm reduction products, today announced that the U.S. Food & Drug Administration (FDA) has cleared an Investigational New Drug (IND) Application to conduct a Phase II-B clinical trial using X-22, a prescription smoking cessation aid in development.

22 Jul 2011

Financial Times examines product development partnerships developing drugs for neglected diseases

The Financial Times examines the rise of product development partnerships (PDPs), which are "non-governmental organizations that generate their own funding and build partnerships with universities, businesses, government and patients in low-income countries to develop new drugs, vaccines, prevention techniques and diagnostics for diseases such as tuberculosis, HIV, malaria, cholera and meningitis."

22 Jul 2011

Medicare Part D prescription drug rebates would increase monthly premiums for seniors

Including Medicare Part D prescription drug rebates in the final debt ceiling package would increase monthly premiums by up to about 40 percent for more than 17 million seniors, according to a new analysis of government data.

22 Jul 2011

Scientists directly link lipid metabolism and cancer-associated cachexia

Scientists from Graz, Austria, have now directly linked lipid metabolism and cancer-associated cachexia. Science reports via its online channel Science Express that mice deficient in the lipid degrading enzyme Adipose Triglyceride Lipase (ATGL) are fully protected against cancer-associated cachexia.

22 Jul 2011

UCSF neurosurgery shows promise against severe epilepsy

Two-thirds of people with severe and otherwise untreatable epilepsy were completely cured of their frequent seizures after undergoing neurosurgery at the University of California, San Francisco Medical Center, according to a new study that examined 143 of these patients two years after their operations.

22 Jul 2011

Renowned neurosurgeon to receive National Urban League's highest honor on July 30

Renowned neurosurgeon Keith L. Black, MD, will receive the National Urban League's highest honor on July 30 during the organization's annual conference in Boston.

22 Jul 2011

HIV-infected MSM more likely to contract HCV through sex

Sexual transmission of hepatitis C virus (HCV) is considered rare. But a new study by researchers at Mount Sinai School of Medicine, working with the Centers for Disease Control and Prevention (CDC), provides substantial evidence that men with HIV who have sex with other men (MSM) are at increased risk for contracting HCV through sex.

22 Jul 2011

GIDAC recommends FDA approval of Janssen's REMICADE for treatment of pediatric UC

Janssen Biotech, Inc., formerly Centocor Ortho Biotech Inc., announced today that the Gastrointestinal Drugs Advisory Committee of the U.S. Food and Drug Administration recommended the approval of REMICADE for the treatment of moderately to severely active ulcerative colitis in pediatric patients who have had an inadequate response to conventional therapy.

22 Jul 2011

A*STAR's ETC, Agilent introduce drug screening platform

Agilent Technologies Inc. and A*STAR's Experimental Therapeutics Centre (ETC) today announced the launch of a drug screening platform within ETC's new Singapore Screening Centre.

22 Jul 2011

Adamis receives U.S. patent for APC-100 to treat prostate cancer

Adamis Pharmaceuticals Corporation, today announced the technology which constitutes its compound APC-100 was recently granted a patent in the United States.

22 Jul 2011

Bristol-Myers Squibb signs definitive agreement to acquire Amira Pharmaceuticals

Bristol-Myers Squibb Company and Amira Pharmaceuticals, Inc., announced today that the companies have signed a definitive agreement under which Bristol-Myers Squibb will acquire privately held Amira Pharmaceuticals, a small-molecule pharmaceutical company focused on the discovery and early development of new drugs to treat inflammatory and fibrotic diseases.

22 Jul 2011

High cost of multiple sclerosis drugs

According to a study released this Wednesday, drugs used in the hope of slowing multiple sclerosis progression may help some patients, but at a very high cost.

21 Jul 2011

Australian anti-cancer company completes $2.6 million placement

Australian monoclonal antibody company, Immune System Therapeutics Limited (IST), today said it completed a private placement to raise $2 million from new and existing private and institutional investors in Australia. Investors have agreed to purchase 5,200,000 shares in the company at a price of $0.50 cents per share resulting in gross proceeds of $2.6 million.

21 Jul 2011

Drugs News and Research

Report on versatility of nitric oxide in arming hosts against pathogens

Medicines Patent Pool can help many but has potential limitations for AIDS drug access in middle-income countries

Circumcision prevents HIV transmission & cocktail of anti-HIV drugs prolong life

Homeless people report using street drugs to treat their pain

Senate Dems push for Medicare drug savings

U.S. healthcare inflation seems to be leveling off

Myelin regulates key protein involved in sending long-distance signals

22nd Century receives FDA approval for X-22 IND to conduct Phase II-B smoking cessation trial

Financial Times examines product development partnerships developing drugs for neglected diseases

Medicare Part D prescription drug rebates would increase monthly premiums for seniors

Scientists directly link lipid metabolism and cancer-associated cachexia

UCSF neurosurgery shows promise against severe epilepsy

Renowned neurosurgeon to receive National Urban League's highest honor on July 30

HIV-infected MSM more likely to contract HCV through sex

GIDAC recommends FDA approval of Janssen's REMICADE for treatment of pediatric UC

A*STAR's ETC, Agilent introduce drug screening platform

Adamis receives U.S. patent for APC-100 to treat prostate cancer

Bristol-Myers Squibb signs definitive agreement to acquire Amira Pharmaceuticals

High cost of multiple sclerosis drugs

Australian anti-cancer company completes $2.6 million placement

Industry Focus eBook - Cell biology (5th edition) eBook

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News